General cardiovascular risk profile for use in primary care: the Framingham Heart Study - PubMed (original) (raw)
General cardiovascular risk profile for use in primary care: the Framingham Heart Study
Ralph B D'Agostino Sr et al. Circulation. 2008.
Abstract
Background: Separate multivariable risk algorithms are commonly used to assess risk of specific atherosclerotic cardiovascular disease (CVD) events, ie, coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure. The present report presents a single multivariable risk function that predicts risk of developing all CVD and of its constituents.
Methods and results: We used Cox proportional-hazards regression to evaluate the risk of developing a first CVD event in 8491 Framingham study participants (mean age, 49 years; 4522 women) who attended a routine examination between 30 and 74 years of age and were free of CVD. Sex-specific multivariable risk functions ("general CVD" algorithms) were derived that incorporated age, total and high-density lipoprotein cholesterol, systolic blood pressure, treatment for hypertension, smoking, and diabetes status. We assessed the performance of the general CVD algorithms for predicting individual CVD events (coronary heart disease, stroke, peripheral artery disease, or heart failure). Over 12 years of follow-up, 1174 participants (456 women) developed a first CVD event. All traditional risk factors evaluated predicted CVD risk (multivariable-adjusted P<0.0001). The general CVD algorithm demonstrated good discrimination (C statistic, 0.763 [men] and 0.793 [women]) and calibration. Simple adjustments to the general CVD risk algorithms allowed estimation of the risks of each CVD component. Two simple risk scores are presented, 1 based on all traditional risk factors and the other based on non-laboratory-based predictors.
Conclusions: A sex-specific multivariable risk factor algorithm can be conveniently used to assess general CVD risk and risk of individual CVD events (coronary, cerebrovascular, and peripheral arterial disease and heart failure). The estimated absolute CVD event rates can be used to quantify risk and to guide preventive care.
Similar articles
- Observed versus predicted cardiovascular events and all-cause death in HIV infection: a longitudinal cohort study.
De Socio GV, Pucci G, Baldelli F, Schillaci G. De Socio GV, et al. BMC Infect Dis. 2017 Jun 12;17(1):414. doi: 10.1186/s12879-017-2510-x. BMC Infect Dis. 2017. PMID: 28606059 Free PMC article. - Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan.
Nakai M, Watanabe M, Kokubo Y, Nishimura K, Higashiyama A, Takegami M, Nakao YM, Okamura T, Miyamoto Y. Nakai M, et al. J Atheroscler Thromb. 2020 Nov 1;27(11):1160-1175. doi: 10.5551/jat.48843. Epub 2020 Feb 6. J Atheroscler Thromb. 2020. PMID: 32023562 Free PMC article. - Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
Bozorgmanesh M, Hadaegh F, Azizi F. Bozorgmanesh M, et al. Int J Clin Pract. 2011 Mar;65(3):264-73. doi: 10.1111/j.1742-1241.2010.02529.x. Int J Clin Pract. 2011. PMID: 21314863 - Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: A Systematic Evidence Report for the U.S. Preventive Services Task Force [Internet].
Lin JS, Evans CV, Johnson E, Redmond N, Burda BU, Coppola EL, Smith N. Lin JS, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 17-05225-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Jul. Report No.: 17-05225-EF-1. PMID: 30234933 Free Books & Documents. Review. - Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population.
D'Agostino RB Sr. D'Agostino RB Sr. J Infect Dis. 2012 Jun;205 Suppl 3(Suppl 3):S362-7. doi: 10.1093/infdis/jis196. J Infect Dis. 2012. PMID: 22577209 Free PMC article. Review.
Cited by
- Cardiovascular Risk in Rheumatoid Arthritis: Considerations on Assessment and Management.
Anyfanti P, Ainatzoglou A, Angeloudi E, Michailou O, Defteraiou K, Bekiari E, Kitas GD, Dimitroulas T. Anyfanti P, et al. Mediterr J Rheumatol. 2024 Sep 30;35(3):402-410. doi: 10.31138/mjr.310824.cri. eCollection 2024 Sep. Mediterr J Rheumatol. 2024. PMID: 39463875 Free PMC article. Review. - H2 FPEF score predicts atherosclerosis presence in patients with systemic connective tissue disease.
Vasilev V, Popovic D, Ristic GG, Arena R, Radunovic G, Ristic A. Vasilev V, et al. Clin Cardiol. 2021 Jul;44(7):946-954. doi: 10.1002/clc.23621. Epub 2021 Jun 2. Clin Cardiol. 2021. PMID: 34075600 Free PMC article. - Cardiovascular risk and midlife cognitive decline in the Study of Women's Health Across the Nation.
Derby CA, Hutchins F, Greendale GA, Matthews KA, Sternfeld B, Everson-Rose SA, Kazlauskaite R, Whitmer RA, Brooks MM. Derby CA, et al. Alzheimers Dement. 2021 Aug;17(8):1342-1352. doi: 10.1002/alz.12300. Epub 2021 Mar 12. Alzheimers Dement. 2021. PMID: 33710770 Free PMC article. - Risk factors for major adverse cardiovascular events after the first acute coronary syndrome.
Okkonen M, Havulinna AS, Ukkola O, Huikuri H, Pietilä A, Koukkunen H, Lehto S, Mustonen J, Ketonen M, Airaksinen J, Kesäniemi YA, Salomaa V. Okkonen M, et al. Ann Med. 2021 Dec;53(1):817-823. doi: 10.1080/07853890.2021.1924395. Ann Med. 2021. PMID: 34080496 Free PMC article. - Agreement between laboratory-based and non-laboratory-based Framingham risk score in Southern Iran.
Rezaei F, Seif M, Gandomkar A, Fattahi MR, Hasanzadeh J. Rezaei F, et al. Sci Rep. 2021 May 24;11(1):10767. doi: 10.1038/s41598-021-90188-5. Sci Rep. 2021. PMID: 34031448 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources